Conformational dynamics and energetic perturbations in human β-spectrin-II mediated by calpain cleavage-related

Reshma V Kizhakethil1, Ashok K Varma2, Om V Bhogale1

  • 1Amity Institute of Biotechnology, Amity University, Bhatan, Somathne, Mumbai Pune Expressway, Panvel, Navi Mumbai, Maharashtra 410206, India.

PubMed

Insights

Missense mutations in beta-II spectrin (SPTB2) disrupt its interaction with µ-calpain, impacting cell signaling and cytoskeletal regulation. This study reveals how cancer-associated mutations in calpain substrates affect protein stability and cellular functions.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cell Biology

Background:

  • Calpains are calcium-dependent proteases regulating cellular functions via substrate cleavage.
  • Missense mutations near calpain cleavage sites (CCRMs) may alter substrate interactions and cellular processes.
  • The specific impact of CCRMs on calpain substrate structure and function remains poorly understood.

Purpose of the Study:

  • To investigate the structural and functional consequences of a V1463M mutation in beta-II spectrin (SPTB2) on its interaction with µ-calpain.
  • To elucidate how this mutation affects substrate stability, binding dynamics, and cellular signaling pathways.
  • To understand the implications of altered SPTB2-µ-calpain interactions in cancer, specifically uterine corpus endometrial carcinoma.

Main Methods:

  • Molecular docking of wild-type and mutant SPTB2 with µ-calpain.
  • Molecular dynamics (MD) simulations to analyze conformational dynamics and stability.
  • Enhanced sampling techniques and steered MD to assess binding energy and mechanical stability.
  • Analysis of RMSD, RMSF, and Rg values to quantify complex stability.

Main Results:

  • The V1463M mutation in SPTB2 results in a less stable complex with µ-calpain, exhibiting increased conformational fluctuations.
  • The wild-type SPTB2-µ-calpain complex demonstrates superior mechanical stability and stronger resistance to dissociation compared to the mutant complex.
  • Binding energy assessments indicate more favorable interactions for the wild-type complex, suggesting impaired binding affinity in the mutant.

Conclusions:

  • The V1463M mutation significantly alters SPTB2 binding to µ-calpain, potentially disrupting calpain-mediated proteolysis.
  • Dysregulated interactions may lead to aberrant cytoskeletal remodeling and downstream signaling, contributing to cellular migration and metastasis.
  • These findings highlight the critical role of CCRMs in disease pathogenesis and provide insights into calpain substrate regulation.